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Introduction
Almost every chemical reaction in a cell is cata lyzed either by a single enzyme or by an enzyme complex. An example is the membrane-bound mo nooxygenase system consisting of two functionally different proteins, the heme protein cytochrome P450 and the flavoprotein NADPH-cytochrome P450 reductase. Mammalian cytochrome P450 en zymes (P450) comprise a super family of membrane-bound hemoproteins (~ 200 different types) involved in the oxidative biotransformation of a wide variety of endogenous and exogenous com pounds, including steroids, therapeuthic drugs and carcinogens (Guengerich, 1995; Gonzalez, 1992) . The mayor part of both enzymes (~ 480 and 680 amino acid residues, respectively) is present in the cytosol of the cell. It is generally accepted that this part of both enzymes is responsible to form a catalytically active P450 : reductase complex (Tamburini and Schenkman, 1986; Strobel et al., 1989; Bern hardt et al., 1988; Voznesensky and Schenkman, 1992) . Both enzymes anchor with their relative short N-terminal membrane-binding domain (~ 22 and 56 amino-acid residues, respectively) in the lipid bilayer of the endoplasmatic reticulum of the liver cell (Vergeres et al., 1989; Uvarov et al., 1989; Black and Coon, 1982) . This work addresses the following question: are the amino-terminal membrane-binding domains of both enzymes the re cognition peptide for forming a catalytically active enzyme complex? To answer this question we mea-0939-5075/2000/0900-0747 $ 06.00 © 2000 Verlag der Zeitschrift für Naturforschung, Tübingen • www.znaturforsch.com • N sured the enzyme activity of the binary system with proteins having different membrane-binding pep tides.
Materials and methods

Chemicals
7-Ethoxycoumarin and 7-hydroxycoumarin were purchased from EGA-Chemie KG (Steinheim, Germany). Nifedipine (NF) (3,5-di-methoxycarbonyl-2,6-dimethyl-4-[2-nitrophenyl]-l,4-dihydroxypyridine) and its oxidized metabolite (3,5-dimethoxycarbonyl-2,6-dimethyl-4-[2-nitrophenyl]-pyridine (NF0^) were purchased from RBJ (Natick, MA, USA). L-a-dilauryl-s«-glycero-3-phosphate and L-a-phosphatidyl-L-serine were purchased from Sigma (Deisenhofen, Germany).
Enzyme preparations
Native human cytochrome P4503A4 (CYP3A4) was purified to gel-electro-phoretically homoge nous state as described by Guengerich et al. (1986) and by Miiller-Enoch (1999) (CYP stands for cytochrome P450). Recombinant human CYP3A4NF14 and human NADPH-P450 reduc tase (reductase) were purchased from Oxford Bio chemical Research, Inc., Oxford, MI (USA). Rat CYP2B1 and CYP1A1 and rat and rabbit NADPH-P450 reductase were purified to electro phoretic homogeneity using procedures described by Guengerich et al. (1982) .
Vesicular reconstituted P450:reductase systems
The procedure utilized was a modification of the method described by Miiller-Enoch et al. (1984) . Phospholipid liposomes were prepared by sonication of a solution of 4 mg L-a-dilauryl-s/?-glycero-3-phosphocholine and 4 mg L-a-phosphatidyl-L-serine in 1 ml of a 0.1 m potassium HEPES (N-[2-hydroxyethyl] piperazine-N'-[2-ethanesulfonic acid]) buffer (pH = 7.6) containing 20 % glycerol (v/v) un til the reaction medium became completely clear. To this phospholipid preparation (PLP) aliquots of the cytochrome P450 forms (native CYP3A4 or re combinant CYP3A4NF14 or CYP2B1 or CYP1 A l) and the reductase forms (human, rat and rabbit) were added in varying molar ratios of P450:reductase:PLP of 1 :X: 1100. respectively. These reconstitu ted vesicular systems were allowed to stand for 2-3 h at 25 °C (Miiller-Enoch et al..1984) . A li quots of these reconstituted P450:reductase sys tems were used for measuring the P450 enzyme activity.
General assays
Nifedipine-oxidase assay: 8 of each of the re constituted vesicular CYP3A4 : reductase systems (native CYP3A4 or recombinant CYP3A4 NF14 with human or rabbit reductase) are incubated with 0.2 mM nifedipine, 5 mM MgCl2 and 0.5 mM N ADPH in 0.1 m potassium HEPES buffer (pH 7.6) to give a final volume of 0.2 m€. The reaction proceeded for 5 min at 37 °C. After stopping the reaction, the HPLC analysis of the oxidized nifedi pine product NFox was performed as described by Miiller-Enoch (1999) .
The 7-ethoxycoumarin O-deethylase activities of rat CYP2B1 and CYP1A1 were assayed using the continuous fluorometric assay described by Ullrich and Weber (1972) . N-terminal amino acid sequences of the enzymes were performed with gel-electrophoretically pure enzymes, using an Applied Biosystems 477A automated Edman Sequenzer. Protein concentrations were estimated using the general method of Lowry et al. (1951) .
Enzyme kinetics
The complexation of the P450 forms with one type of reductase can be described very generally by the mass action equation where the two en zymes form a binary complex (P450:reductase) (Miiller-Enoch et al., 1984; Miiller-Enoch, 1993) [
with the dissociation constant, KD
The reaction velocity, v, is the product formation rate, [dP]/dt which can be factorized into three dif ferent terms:
The reaction velocity is proportional to: (i) The pro tein complex concentration ([complex] 
The predicted enzyme activity is obtained from Eqns (2) and (5) 
Results and Discussion
In the following experiments the complexation of the two types of proteins is investigated by measuring the enzyme activity, A, for different ini tial P450 and reductase concentrations. It is only important to know the ratio of both enzymes,
Nifedipine oxidase activity
First, we investigated the enzyme activity (nifed ipine oxidase activity) for two human cytochrome P450 forms which differs only in the length of their membrane-binding domains. Compared to the na tive form (CYP3A4) (Beaune et al., 1986) , the re combinant form (CYP3A4NF14) (Gillam et al., 1993) is truncated by 10 amino acid residues. The results are shown in Fig. 1 .
The cycle or turnover time, x (=1 lk%) (Gruler and Müller-Enoch, 1991) , can be obtained by ex trapolating the enzyme activity for very high re ductase concentrations. The catalytic cycle time of the native form is 2.5 ± 0.2 s and 2.8 ± 0.2 s of the recombinant form, respectively. The maximal enzyme activity is essentially the same for both forms (24 ± 2 and 21.5 ± 2 ([nmol(NF)ox] [nmol {f*450]_1 -min-1), respectively). Such a result was expected because the primary structure of both cy tosolic parts is the same (Beaune et a l, 1986; Gil lam et a l, 1986) . We have demonstrated that the action of the catalytic center where the chemical reaction takes place is not influenced by the mem brane-binding peptide but that the complexation process is influenced by the membrane-binding domains. In case of the native CYP3A4 the disso ciation constant divided by [P450JO is 0.3 ± 0.05 and for the recombinant CYP3A4NF14 the same ratio is 2.0 ± 0.2. This shows that the affinity of the reductase to native CYP3A4 is much higher than for the recombinant CYP3A4NF14. This re sult demonstrates that the membrane-binding do mains are essential in the complexation process because both P450 forms used differ only in the primary structure of their binding domain. In an additional experiment, the working en zyme complex is formed of proteins of different species using the human P450 form (CYP3A4) and the rabbit reductase. The catalytic cycle time is 2.8 ± 0.2 s with the rabbit reductase and 2.5 ± 0.1 s for the human reductase. Obviously, the catalytic cycle time is independent of the reductase used. However, complex formation of the monooxygen ase system with enzymes of different species is dif ferent. The dissociation constant K D divided by [P450]o is 4.7 ± 0.2 for the rabbit reductase, and 0.3 ± 0.05 for the human reductase. These results are important to understand the enzymes as mo lecular machines since the rabbit reductase differs significantly by 13 amino acid residues in its membrane-binding domain compared with that of the human reductase whereas the cytosolic part of both proteins have nearly the same primary struc ture (Porter and Kasper, 1985; Katagiri et al., 1986; Hanui et al., 1989; Shephard et al., 1992) . Now, the results of Müller-Enoch (1999) are understandable where he investigated the enzyme activity of one human P450 form (CYP3A4) with three different reductase forms (man, rabbit, and rat). The nifedi pine oxidase enzyme activity was reduced by a factor of 5 using the animal reductase in the binary complex at a fixed reductase : P450 ratio of 2.
7-Ethoxycoumarin O-deethylase activity
In the last step, two different rat P450 forms (CYP2B1 and CYP1A1) are used in combination with the rat reductase. The results are shown for the 7-ethoxycoumarin O-deethylase activity in Fig. 2 . The catalytic cycle time of the CYP1A1 re ductase complex is 0.6 ± 0.05 s and of 1.8 ± 0.1 s. This shows that the maximal enzyme activity is different for both forms (100 ± 7 and 33 ± 2 ([nmol(7-hydroxycoumarin)] • [nmol P450] ~1 • min-1), respectively). This can be explained by the dif ferent primary structure of both forms at the cata lytic center. The complex formation for both P450 forms with the same reductase is different. The normalized dissociation constant AT D/[P450]o is 1.7 ±0.2 (CYP1A1) and 2.3 ± 0.2 (CYP2B1). Again, the membrane-binding peptides of both forms differ significantly by 16 amino-acid resi dues.
Conclusions
The enzyme activity depends basically on two protein domains of the binary complex: The cyto solic catalytic domain and the membrane-binding domain: (i) The formation of the binary complex depends essentially on the membrane-binding do- main, (ii) The catalytic cycle time for the catalytic reaction depends on the cytosolic domain. Hence, the enzyme activity can be optimized by two dif ferent ways: Either by changing the catalytic do main to make the chemical reaction very fast or by changing the membrane-binding domain to produce a large number of working binary com plexes. Our results are of general interest for under standing the self-organization of complex mem brane-bound molecular machines. The above dis cussed monooxygenase system is one example but other complex systems are the intracellular signal transduction chains where membrane-bound pro teins are involved. In the case of the monoxygenase system the two enzymes form a working com plex which has a life time of approximately three times the catalytic cycle time (Gruler and Müller-Enoch, 1991) . But in the case of a signal transduc tion chain the lifetime of the binary complex formed must be very short. For example in the G-protein driven signal chain where one activated membrane-bound receptor activates one to two thousands membrane-attached G-proteins per se cond. Likewise, our results can be used to create tools for making artificial self-organized mem brane-bound molecular machines. E.g. one has the task to bring the functional group like a catalytical active group of a polymer to a specific macromolecular target molecule. If the macromolecules are anchored in a lipid matrix then the anchor has to be constructed in such a way that the elastic mem brane distortions lead to attractive forces (Gruler and Sackmann, 1977; Marcerou et al., 1984; Leibler, 1986 ).
